CNR Institutional Research Information System

Comment on A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia. [Oncotarget. 2012]

Enhancing the effectiveness of nucleoside analogs with mTORC1 blockers to treat acute myeloid leukemia patients

Chiarini F
2013

Abstract

Comment on A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia. [Oncotarget. 2012]
2013
Istituto di Genetica Molecolare "Luigi Luca Cavalli Sforza"
Inglese
WOS:000323170200005
12
12
1815
1816
2
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3735688/pdf/cc-12-1815.pdf
Sì, ma tipo non specificato
targeted therapy
combination therapy
leukemia initiating cells
PI3K
Akt
mTOR
cell cycle
apoptosis
autophagy
translation
5
info:eu-repo/semantics/article
262
Martelli, Am; Lonetti, A; Amadori, S; Mccubrey, Ja; Chiarini, F
01 Contributo su Rivista::01.01 Articolo in rivista
none
01.01 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/270588
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 3
social impact